<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCT</journal-id><journal-title-group><journal-title>Journal of Cancer Therapy</journal-title></journal-title-group><issn pub-type="epub">2151-1934</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jct.2011.21008</article-id><article-id pub-id-type="publisher-id">JCT-4263</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  A New Diterpene Extracted from Daphne Mucronata, Effects on Human K562 and CCRF-CEM Cell Lines
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ehdi</surname><given-names>Hedayati</given-names></name><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Razieh</surname><given-names>Yazdanparast</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marjan</surname><given-names>Zarif Yeganeh</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Laleh</surname><given-names>Hoghooghi Rad</given-names></name></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fereidoun</surname><given-names>Azizi</given-names></name></contrib></contrib-group><author-notes><corresp id="cor1">* E-mail:<email>hedayati@endocrine.ac.ir(EH)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>03</month><year>2011</year></pub-date><volume>02</volume><issue>01</issue><fpage>71</fpage><lpage>75</lpage><history><date date-type="received"><day>October</day>	<month>9th,</month>	<year>2010</year></date><date date-type="rev-recd"><day>November</day>	<month>12th,</month>	<year>2010</year>	</date><date date-type="accepted"><day>November</day>	<month>17th,</month>	<year>2010.</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Daphne Mucronata extract has a decreasing effect on the size of breast adenocarcinoma in rats. So in this study, the effect of Daphne Mucronata purified diterpene were investigated on co culture of human monocytes and two human leukemia cell lines (K562, CCRF-CEM). Materials and Methods: Each cell line mono-layer culture, in log phase growth, was treated with 10 to 160 μL of the extract (1 g/ml leave powder) and purified compound (0.94 nM). For a comparative study, Taxol (5 to 40 μM) was used in the presence and absence of LPS. Human monocytes were isolated by adhesion method. TNF-α in cultured media were measured by sensitive biotin-streptoavidin ELISA method. Results: Fifty percent of growth inhibition was shown by 160 μL (1:100 dilution, 0.5 g of the powdered leaves/ml) of the extract and 0.94 nM of the purified component, and there was more inhibition in K562 cells (P &lt; 0.05). Four fold increases in growth inhibition was shown in co culture of isolated human monocytes and leukemia cell lines. There was a direct relationship between monocytes TNF-α secretion and growth inhibition degree. Conclusion: Daphne Mucronata extract and its purified diterpene through increasing monocytes TNF-α releasing, potentially inhibit Leukemia cell line.
 
</p></abstract><kwd-group><kwd>TNF-α</kwd><kwd> Leukemia</kwd><kwd> Daphne Mucronata</kwd><kwd> K562</kwd><kwd> CCRF-CEM</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Various Daphne species (Tymelaeaceae) have been used to treat cancer since 200 AD [1-4]. There are so many reports on effects of Tymelaeaceae family in different parts of body, for example their; anti leukemia [<xref ref-type="bibr" rid="scirp.4263-ref5">5</xref>], emergency abortion [<xref ref-type="bibr" rid="scirp.4263-ref6">6</xref>], anti tumor [<xref ref-type="bibr" rid="scirp.4263-ref7">7</xref>], anti gout [<xref ref-type="bibr" rid="scirp.4263-ref8">8</xref>], anti microbial [<xref ref-type="bibr" rid="scirp.4263-ref9">9</xref>] and anti inflammatory [<xref ref-type="bibr" rid="scirp.4263-ref10">10</xref>] effects of Tymelaeaceae family [11,12].We reported inhibition of nucleic acid synthesis [<xref ref-type="bibr" rid="scirp.4263-ref13">13</xref>], inhibition of cell adhesion [<xref ref-type="bibr" rid="scirp.4263-ref14">14</xref>], and anti rat breast adenocarcinoma effect [<xref ref-type="bibr" rid="scirp.4263-ref15">15</xref>] of Daphne mucronata and Dendrostellera lessertii [<xref ref-type="bibr" rid="scirp.4263-ref16">16</xref>] in Iranian folk medicine. Therefore, as part of our studies on plants for new anticancer agents with emphasis on Tymelaeaceae family, we examined the cytotoxicity and anti-tumor activity of an alcohol: water (1:1, v/v) extract of Daphne mucronata leaves and one of its purified diterpene (Gnidilatimonoein) against two types of human leukemia cell lines. After exploring the high anti-tumor activity of plant extract, and its purified compound on human leukemia cell lines, we evaluated the mode of action of this anti-cancer plant. In that respect, we investigated the effects of the plant extract, and the purified component, and Taxol (an antineoplastic natural agent from the bark of the Pacific yew tree and with established mechanism of action) on the TNF-α secretion by the isolated human monocytes in the absence or the presence of LPS. Based on the literature data, Taxol inhibits cell growth by two mechanisms of cell cycle dependent and independent pathways. In cell cycle independent pathway, it rapidly down-regulates TNF-α receptors and stimulates TNF-α release by the isolated human monocytes in a similar way to LPS [17-20]. Leukemia treatment is an important medical problem. So in this study we investigated the Daphne mucronata extract and its purified diterpene (Gnidilatimonoein) effects on the isolated healthy human monocytes and the co-culture of human monocytes and two, chronic and acute, leukemia cell lines in the presence and absence of LPS as monocytes stimulant.</p></sec><sec id="s2"><title>2. Materials &amp; Methods</title><p>Human tumor necrosis factor alpha (TNF-α), Salmonella typhimurium LPS, RPMI 1640, Neomycin, Penicillin and other chemicals was purchased from Sigma Chemical Co. (Sigma-Aldrich Chime GmbH, Germany). Radioactive NaI<sup>125</sup> was obtained from Atomic Energy Agency of Iran. Human leukopakes of normal donors were obtained from Blood Transfer Institute of Iran. Human leukemia cell lines, K562 (Chronic Mylocytic Leukemia), CCRF-CEM (Acute Lymphocytic Leukemia) were obtained from Iranian Cell Bank.</p><sec id="s2_1"><title>2.1. Plant Material</title><p>Aerial parts of Daphne mucronata (Magnoliopsida, Malvales, Thymelaeaceae, Daphne, mucronata) were collected from suburb of Kermanshah province at the end of spring. A voucher specimen was deposited in the herbarium of the faculty of Science, Tehran University (7658 THE). The plant material was dried, in the absence of direct light. The dried leaves were separated from the stems and powdered. The powder was kept in a closed container in a cold room.</p></sec><sec id="s2_2"><title>2.2. Extraction</title><p>Extract solution was made with 500 g of powder in 7.5 liter of the solvent mixture and finally was concentrated to 500 mL. Briefly, each 100 gram of the powder extracted with 3 &#215; 500 mL of EtOH-H2O (50:50, v/v), placed under agitation during 24 h. After filtration, the extracts are concentrated with a rotary evaporator, under reduced pressure, finally kept at freezer (–20˚C) for further investigation [21-23].</p></sec><sec id="s2_3"><title>2.3. Purification</title><p>On the basis of Yazdanparast and her coworkers’ method, its active diterpene (Gnidilatimonoein) extracted and purified [<xref ref-type="bibr" rid="scirp.4263-ref24">24</xref>].</p></sec><sec id="s2_4"><title>2.4. LC50 Estimation</title><p>The biological potency of plant extract was established through using brine shrimp (Artemia Solina) test as described by Mclaughlin and coworker [<xref ref-type="bibr" rid="scirp.4263-ref25">25</xref>]. Different amount of extract were transferred to sample vials containing 10 shrimps, 5 mL with sea water and a drop of dry yeast suspension (3 mg/mL). The vials were kept under the light and in the room temperature. After 24 hours the survivors were counted and their death percentage were determined at each dose. In the case of death in the controlled vials, the data were corrected by using the following formula: % death = [(test –control)]/ control 100 The LC50 were determined for each dose by using the probity analysis method which described by Finney [<xref ref-type="bibr" rid="scirp.4263-ref26">26</xref>].</p></sec><sec id="s2_5"><title>2.5. Monocytes Isolation</title><p>Human monocytes were isolated from leukopakes by Cell adherence separation method. Briefly, cells were washed twice with Phosphate Buffer Saline (PBS), counted and suspended in the culture media at a final concentration of 5 &#215; 10<sup>6</sup> cells/mL. After two hours of incubation at 37˚C in an incubator with 5% CO<sub>2</sub> atmosphere, the non adherent cells were removed aseptically followed by 3-4 times of washing with cold PBS. The adherent cells were gently scraped with a rubber policeman in the presence of PBS/EDTA solution. The cells were finally re-suspended in the culture media at a concentration of 5 &#215; 10<sup>5</sup> cells/mL [<xref ref-type="bibr" rid="scirp.4263-ref27">27</xref>].</p></sec><sec id="s2_6"><title>2.6. Cell Cultures and Treatments with Stimuli</title><p>A total of 10<sup>6</sup> cells were incubated in duplicate, in 24- well plate. Each well contained the medium (RPMI 1640 containing 10% BCF, 100 IU penicillin, plus 100 μg/mL of streptomycin). After 20 hours incubation the cells in incubator at 37˚C in a 5% CO<sub>2</sub> atmosphere, various concentrations of Daphne mucronata extract and its purified diterpene were added to each well up to a final volume of 1mL. The cultures were incubated with the extract and purified diterpene for 24 hours at 37˚C in a 5% CO<sub>2</sub> atmosphere. The stimuli (crude extract and purified diterpene) were: plant extract (0 mg/ml, 10 mg/ml, 20 mg/ml, 40 mg/ml, 80 mg/ml, and 160 mg/ml of a 1:100 dilution of the original plant extract with a concentration corresponding to 1 g plant leaves powder per mL), and its purified diterpene (0.94 nM), in the presence and absence of LPS (100 ng/mL). The effect was compared with Taxol (0, 5 μM, 10 μM, 20 μM and 40 μM) as a positive control.</p></sec><sec id="s2_7"><title>2.7. Determination of hTNF-α</title><p>The hTNF-α level in the supernatant of each culture monocytes sample was achieved by our developed biotin-streptavidin enzyme immunoassay system [<xref ref-type="bibr" rid="scirp.4263-ref28">28</xref>]. Each sample supernatant (or the diluted sample 1:10) was added to a well of a 96 well plate (100 μL/well). The plate was incubated at room temperature for one hour on a plate shaker. After washing, 100 μL of biotinylated antibody was added to each well, incubated at room temperature for one hour on a plate shaker and rinsed with the wash buffer (PBS with 0.05% TWEEN 20). Then 100 μl of streptavidin-HRP conjugate was added to each well followed by 30 minutes of incubation at room temperature while shaking on the plate shaker. Finally the plate was washed and the color was developed by adding the substrate buffer solution containing TMB and H2O2 (100 μL/well). The reaction was stopped after 30 minutes by the addition of 100 μl of 1.8 M sulfuric acid. The optical density of each well was recorded at 450 nm in an ELISA plate reader (Spectra, Tecan, Austria). The levels of the TNF-α in each sample were established via the use of the corresponding calibration graph.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Based on experiments carried out on shrimp test, biological potency of Daphne mucronata extract LC50 was 0.062 mg/ml plant leave and 0.3 mg mg/ml plant stem. The effects of Daphne mucronata extract and its purified diterpene (Gnidilatimonoein, MW 663) on acute and chronic leukemia cell lines are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. These data clearly show that the purified component is biologically active. In the presence of the human monocytes, and under all identical conditions, cell viability decreased almost by a factor of four (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In other words, the concentration of the plant extract or the purified component required a half reduction in cell number, decreased considerably and statistically significant for the crude extract and also for the purified component (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Determination of TNF-α in the cell culture media of the co-culture revealed that under the effect of the plant extract and its purified active component (<xref ref-type="fig" rid="fig3">Figure 3</xref>) the concentration of TNF-α increase in a dose dependent way. It is interesting to note that the effects of the purified compound and LPS on TNF-α secretion by the monocytes are neither addition nor synergistic.</p><p>The results are presented as the mean &#177; SD of three independent experiments in duplicate.</p><p>Comparison between two groups was done with t-test and between groups according ANOVA test, (the significance consider for P ≤ 0.05).</p></sec><sec id="s4"><title>4. Discussion</title><p>Tymelaeaceae family has been used to treat diseases from many years ago [<xref ref-type="bibr" rid="scirp.4263-ref2">2</xref>]. Daphne is the most important genus in the Tymelaeaceae family. There are many reports about Daphne therapeutic effects [5-8]. Daphne mucronata is specific to Iranian folk medicine. At first we reported the effects of its alcohol: water inhibition on nucleic acid synthesis and cell adhesion [13,14]. Our investigations showed that Daphne Mucronata extract has a decreasing effect on the size of breast adenocarcinoma in rats and stimulate TNF-α releasing from monocytes [<xref ref-type="bibr" rid="scirp.4263-ref15">15</xref>]. Taxol is an antineoplastic natural agent which extracted from the bark of the Pacific yew tree and established as an effective drug for many types of cancers [16-18]. Based on the literature data, Taxol inhibits cell growth by cell cycle independent pathway through mo-</p><p>nocytes/macrophage TNF-α release stimulation [16,18]. On the basis of our reported data, alcohol: water extract of Daphne mucronata and its purified component showed similar effects on the isolated healthy human monocytes activation [15,29]. In this study after exploring the high anti-tumor activity of plant extract, and its purified diterpene (Gnidilatimonoein) on human leukemia cell lines, we evaluated the mode of action of this anticancer plant. In that respect, we investigated the effects of the plant extract, and the purified component, on TNF-α secretion by the isolated human monocytes in the absence or the presence of LPS. The co-culture of human monocytes and two, chronic and acute leukemia cell lines showed non additive and non synergistic properties between the plant extract and LPS. Based on these observations, it may be concluded that the higher sensitivity of K562 and CCRF-CEM cells to Daphne mucronata, in the co-culture samples, is most probably due to the secretion of TNF-α by the monocytes. We hope this diterpene, after evaluating its side effects; become an effective drug against human leukemia.</p></sec><sec id="s5"><title>5. Acknowledgment</title><p>We are thankful to Endocrine Research Center of Shahid Beheshti University of Medical Sciences for providing the financial support of this investigation. The authors also wish to thank Prof. David L. Smith for providing the FAB/MS of the purified active components of D. mucronata.</p></sec><sec id="s6"><title>REFERENCES</title></sec><sec id="s7"><title>Abbreviation List</title><p>Enzyme Linked Immunosorbent Assay (ELISA), Ethylene Diamine Tetra Acetic acid (EDTA), Lipopolysaccharide (LPS), Phosphate Buffer Saline (PBS), Roswell Park Memorial Institute (RPMI), Tumor Necrosis Factor alpha (TNF-a)</p></sec></body><back><ref-list><title>References</title><ref id="scirp.4263-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">F. Abe, Y. Iwase, T. Yamauchi, K. Kinjok and S. Yaga, “Daphnane Diterpenoids from the Bark of Winstromia Etusa,” Phytochemistry, Vol. 44, 1997, pp. 643-646. doi:10.1016/S0031-9422(96)00602-4  </mixed-citation></ref><ref id="scirp.4263-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple"> 
K. Baba, K. Takeuchi, F. Hamaski and M. Kozawa, “Chemical Studies on the Constituents of the Thimelaeceous Plants,” Thunb Chemical Pharmaceutical Bulletin, Vol. 34, 1986, pp. 595- 598.</mixed-citation></ref><ref id="scirp.4263-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple"> 
R. Kasai, K. Lee and H. Huang, “Antitumor Agent 40. Genkawaphnin a Potent Anti-Leukemic Diterpene from Daphne Genkawa,” Phytochem, Vol. 20, 1981, pp. 2592- 2595. </mixed-citation></ref><ref id="scirp.4263-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple"> 
S. M. Kupchan and R. L. Baxter, “Mezerin: Antileukemic Principle Isolated from Daphne Mezerum,” Science, Vol. 187, 1975, pp. 652-654. doi:10.1126/science.1114315 </mixed-citation></ref><ref id="scirp.4263-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple"> 
K. Larsen, “Medicinal and Poisonous Plants. IV. Daphne Mezereum,” Nord Medical, Vol. 15, 1962, pp. 227-228. </mixed-citation></ref><ref id="scirp.4263-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple"> 
S. M. Kupchan and R. L. Baxter, “Mezerein: Antileukemic Principle Isolated from Daphne Mezereum L,” Science, Vol. 187, 1975, pp. 652-653. doi:10.1126/science.1114315 </mixed-citation></ref><ref id="scirp.4263-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple"> 
X. M. Zhang, C. M. Wang, Y. H. Cen, H. S. Huo, J. Y. Ba, Z. T. Liu, et al., “Clinical Observation and Preliminary Study of Termination of Early Pregnancy by Administration of Yellow Daphne,” Shengzhi Yu Biyun, Vol. 4, 1984, pp. 42-46. </mixed-citation></ref><ref id="scirp.4263-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple"> 
T. Noro, Y. Oda, T. Miyase, A. Ueno and S. Fukushima, “Inhibitors of Xanthine Oxidase from the Flowers and Buds of Daphne Genkwa,” Chemical Pharmaceutical Bulletin (Tokyo), Vol. 31, 1983, pp. 3984-3987. </mixed-citation></ref><ref id="scirp.4263-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple"> 
F. Cottiglia, G. Loy, D. Garau, C. Floris, M. Casu, R. Pompei, et al., “Antimicrobial Evaluation of Coumarins and Flavonoids from the Stems of Daphne Gnidium L,” Phytomedicine, Vol. 8, 2001, pp. 302-305. doi:10.1078/0944-7113-00036 </mixed-citation></ref><ref id="scirp.4263-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple"> 
E. Yesilada, H. Taninaka, Y. Takaishi, G. Honda, E. Sezik, H. Momota, et al., “In Vitro Inhibitory Effects of Daphne Oleoides ssp. Oleoides on Inflammatory Cytokines and Activity-Guided Isolation of Active Constituents,” Cytokine, Vol. 13, No. 6, 2001, pp. 359-364. doi:10.1006/cyto.2001.0838 </mixed-citation></ref><ref id="scirp.4263-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple"> 
D. Parish, “Daphne Parish: Nursing Freedom,” Nursing, Vol. 4, No. 24, 1990, pp. 19-20. </mixed-citation></ref><ref id="scirp.4263-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple"> 
T. Nikaido, T. Ohmoto and U. Sankawa, “Inhibitors of Adenosine 3’,5’-Cyclic Monophosphate PhosphodiEsterase in Daphne Genkwa Sieb,” Chemical Pharmaceutical Bulletin (Tokyo), Vol. 35, No. 2, 1987, pp. 675- 681. </mixed-citation></ref><ref id="scirp.4263-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Mianabadi and R. Yazdanparast, “Inhibition of Substrate-Tumor Cell Adhesion under the Effect of Gnidilatimonoein Purified from Daphne Mucronata,” American Journal of Chinese Medicine, Vol. 32, No. 3, 2004, pp. 369-376. doi:10.1142/S0192415X04002028 </mixed-citation></ref><ref id="scirp.4263-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple"> 
R. Yazdanparast and H. Sadeghi, “Nucleic Acid Synthesis in Cancerous Cells under the Effect of Gnidilatimonoein from Daphne Mucronata,” Life Sciences, Vol. 74, No. 15, 2004, pp. 1869-1876. doi:10.1016/j.lfs.2003.08.039 </mixed-citation></ref><ref id="scirp.4263-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Hedayati, R. Yazdanparast and F. Azizi, “Daphne Mucronata Extracts Effects on down Regulation of TNF-α Receptors on Cultured Human Monocytes,” Yakhte, Vol. 27, No. 7, 2005, pp. 152-157. (Persian) </mixed-citation></ref><ref id="scirp.4263-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Hedayati, R. Yazdanparast, B. Jafari and F. Azizi, “Dendrostellera Lessertii Extract Effects on TNF-α Release and Its Receptors down Regulation on Cultured Human Monocytes,” Pejouhesh, Vol. 29, No. 4, 2006, pp. 337-342. (Persian) </mixed-citation></ref><ref id="scirp.4263-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple"> 
B. Beatler, N. Krochin, I. W. Milsark, C. Luedke and A Cerami, “Control of Cachepsin (Tumor Necrosis Factor) Synthesis, Mechanism of Endotoxin Reistance,” Science, Vol. 232, 1986, pp. 977-980.  
doi:10.1126/science.3754653 </mixed-citation></ref><ref id="scirp.4263-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple"> 
A. H. Ding, F. Porteu, E. Sanchez and C. E. Nathan, “Shared Action of Endotoxin and Taxol on TNF-Receptor and TNF Release,” Science, Vol. 284, 1990, pp. 370-373. doi:10.1126/science.1970196 </mixed-citation></ref><ref id="scirp.4263-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple"> 
E. A. Carswell, L. J. Old, R. L. Kassel, S. Green, N. Fiore and B. Williamson, “An Endotoxine Induced Serum Factor that Cause Necrosis Tumors,” Proceedings of National Academy Sciences (USA), Vol. 72, 1975, pp. 3665-3668. doi:10.1073/pnas.72.9.3666 </mixed-citation></ref><ref id="scirp.4263-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple"> 
J. N. Allen, S.A. Moore and N. W. Wewers, “Taxol Enhance but Not Induced IL-1 Beta and TNF-α Production,” Clinical Research, Vol. 40, 1992, p. 744. </mixed-citation></ref><ref id="scirp.4263-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. O. Jianchu and C. H. Jia?an, “Advance on the Research of the Bioactivity of Daphne Plants,” Natural Product Research and Development, Vol. 15, No. 2, 2003, pp. 167-170. </mixed-citation></ref><ref id="scirp.4263-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. O. Jianchu, Z. H. Jun and W. Wenxue, “Action of Daphne Genkwa Alcohol Extract on the Digestive Enzymes of Abraxas Miranda and Pieris Rapae,” Journal of Central South Forestry University, Vol. 21, No. 1, 2001, pp. 5-9. </mixed-citation></ref><ref id="scirp.4263-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple"> 
T. Vetrichelvan and M. Jegadeesan, “Effect of Alcohol Extract of Achyranthes Aspera Linn on Acute and Subacute Inflammation,” Phytotherapy Research, Vol. 17, No. 1, 2003, pp. 77- 79. doi:10.1002/ptr.1070  </mixed-citation></ref><ref id="scirp.4263-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Mianabadi, E. Rivera and R. Yazdanparast, “A New Diterpene Ester from the Leaves of Daphne Mucronata,” Journal of Tropical Medical Plants, Vol. 4, 2003, pp. 1-4. </mixed-citation></ref><ref id="scirp.4263-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple"> 
B. N. Meyer, N. R. Ferringne, J. E. Putnam, L. B. Jacobsen, D. E. Nicholas and J. L. Mclmaughlin, “Brine Shrimp: A Convenient General Bioassay for Active Plant Constituents,” Plant Medica, Vol. 45, 1982, pp. 31-34. doi:10.1055/s-2007-971236 </mixed-citation></ref><ref id="scirp.4263-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple"> 
D. J. Finney, “Probit Analysis,” 3rd Edition, Cambridge University Press, Cambridge, 1971. </mixed-citation></ref><ref id="scirp.4263-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple"> 
S. Bunnett and S. N. Berit, “Variables in the Isolation and Culture of Human Monocytes that are of Particular Relevance to Studies of HIV,” Journal of Leukocyte Biology, Vol. 56, 1994, pp. 236-240. </mixed-citation></ref><ref id="scirp.4263-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Hedayati, R. Yazdanparast and F. Azizi, “Determination of Human Tumor Necrosis Factor Alpha by a Highly Sensitive Enzyme Immunoassay,” Biochemical and Biophysical Research Communications, Vol. 289, 2001, pp. 295-298. doi:10.1006/bbrc.2001.5886 </mixed-citation></ref><ref id="scirp.4263-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple"> 
M. Hedayati, R. Yazdanparast, H. Fasihi and F. Azizi, “Anti-tumor Activity of Daphne Mucronata Extract and Its Effects on TNF-α-Receptors and TNF-α Release in Cultured Human Monocytes,” Pharmaceutical Biology, Vol. 41, 2003, pp. 194-198. doi:10.1076/phbi.41.3.194.15093 </mixed-citation></ref></ref-list></back></article>